Historically, brain tumor classification has been solely based on histopathological features [5], whereas the latest editions incorporate genetic and epigenetic information, such as molecular markers (e.g., IDH mutation, 1p/19q codeletion, etc.)and DNA methylation profiles [6,7]. Here, IDH1 is linked to brain neoplasm.